BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29756456)

  • 1. No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience.
    Stekler JD; Tapia K; Maenza J; Stevens CE; Ure GA; O'Neal JD; Lane A; Mullins JI; Coombs RW; Holte S; Collier AC
    AIDS Res Hum Retroviruses; 2018 Aug; 34(8):657-666. PubMed ID: 29756456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection.
    Cárdenas AM; Baughan E; Hodinka RL
    J Clin Virol; 2013 Dec; 58 Suppl 1():e97-e103. PubMed ID: 24113294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection.
    Wratil PR; Rabenau HF; Eberle J; Stern M; Münchhoff M; Friedrichs I; Stürmer M; Berger A; Kuttner-May S; Münstermann D; Lucht A; Meixenberger K; Bannert N; Keppler OT
    Med Microbiol Immunol; 2020 Apr; 209(2):139-150. PubMed ID: 32036450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Testing Algorithm Performance in a Low-Prevalence Environment.
    Martin EG; Cornett J; Mohammed DY; Salaru G
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S35-S40. PubMed ID: 31977973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
    Fordan S; Bennett B; Lee M; Crowe S
    J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective study in three regions of the United States.
    Pandori MW; Westheimer E; Gay C; Moss N; Fu J; Hightow-Weidman LB; Craw J; Hall L; Giancotti FR; Mak ML; Madayag C; Tsoi B; Louie B; Patel P; Owen SM; Peters PJ
    J Clin Virol; 2013 Dec; 58 Suppl 1():e92-6. PubMed ID: 24342485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
    Rosenberg NE; Kamanga G; Phiri S; Nsona D; Pettifor A; Rutstein SE; Kamwendo D; Hoffman IF; Keating M; Brown LB; Ndalama B; Fiscus SA; Congdon S; Cohen MS; Miller WC
    J Infect Dis; 2012 Feb; 205(4):528-34. PubMed ID: 22207651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2.
    Zbinden A; Dürig R; Shah C; Böni J; Schüpbach J
    PLoS One; 2016; 11(6):e0157690. PubMed ID: 27310138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection.
    Manak MM; Jagodzinski LL; Shutt A; Malia JA; Leos M; Ouellette J; Akapirat S; Colby DL; Phanuphak N; Eller LA; Robb ML; de Souza M; Ananworanich J; Peel SA;
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31217270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men.
    Stekler JD; O'Neal JD; Lane A; Swanson F; Maenza J; Stevens CE; Coombs RW; Dragavon JA; Swenson PD; Golden MR; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e119-22. PubMed ID: 24342471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of the new Bio-Rad HIV screening test, Access HIV combo V2.
    Guiraud V; Ciczora Y; Cardona M; Defer C; Gréaume S; Nogues D; Gautheret-Dejean A
    J Clin Microbiol; 2024 May; 62(5):e0009524. PubMed ID: 38534108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.